Agostino Tafuri

Pubblicazioni

Titolo	Pubblicato in	Anno
A rare BCR-ABL1 transcript in Philadelphia-positive acute myeloid leukemia. case report and literature review	BMC CANCER	2019
Central nervous system immune reconstitution inflammatory syndrome after autologous stem cell transplantation	BONE MARROW TRANSPLANTATION	2019
Clinical and antitumor immune responses In Relapsed/Refractory Follicular Lymphoma patients after intranodal injections of IFNα-Dendritic Cells and Rituximab	CLINICAL CANCER RESEARCH	2019
The metronomic all-oral DEVEC is an effective schedule in elderly patients with diffuse large b-cell lymphoma	INVESTIGATIONAL NEW DRUGS	2019
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia.	BLOOD	2019
Metabolic reprogramming promotes myogenesis during aging	FRONTIERS IN PHYSIOLOGY	2019
Phosphoproteomic Landscaping Identifies Non-canonical cKIT Signaling in Polycythemia Vera Erythroid Progenitors	FRONTIERS IN ONCOLOGY	2019
Acute Promyelocytic Leukemia (APL) in Very Elderly Patients: Real-Life behind Protocols	BLOOD	2019
Complete response in advanced breast cancer patient treated with a combination of capecitabine, oral vinorelbine and dasatinib	EXPERIMENTAL HEMATOLOGY & ONCOLOGY	2018
Serum Free Light Chains Removal by HFR Hemodiafiltration in Patients with Multiple Myeloma and Acute Kidney Injury. a Case Series	KIDNEY & BLOOD PRESSURE RESEARCH	2018
Differential proteomic profile of leukemic CD34+ progenitor cells from chronic myeloid leukemia patients	ONCOTARGET	2018
Biological aspects of mTOR in leukemia	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2018
Prognostic factors for thrombosis-free survival and overall survival in polycythemia vera. A retrospective analysis of 623 PTS With long follow-up	LEUKEMIA RESEARCH	2018
The calreticulin control of human stress erythropoiesis is impaired by JAK2V617F in polycythemia vera	EXPERIMENTAL HEMATOLOGY	2017
Hyperspectral Raman imaging of human prostatic cells. An attempt to differentiate normal and malignant cell lines by univariate and multivariate data analysis	SPECTROCHIMICA ACTA. PART A, MOLECULAR AND BIOMOLECULAR SPECTROSCOPY	2017
Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells	ONCOTARGET	2017
Inhibition of mTOR kinase as a therapeutic target for acute myeloid leukemia	EXPERT OPINION ON THERAPEUTIC TARGETS	2017
Targeting the Akt, GSK-3, Bcl-2 axis in acute myeloid leukemia	ADVANCES IN BIOLOGICAL REGULATION	2017
Energetic mitochondrial failing in vitiligo and possible rescue by cardiolipin	SCIENTIFIC REPORTS	2017
Tramesan, a novel polysaccharide from trametes versicolor. structural characterization and biological effects	PLOS ONE	2017

ERC

LS1_9
LS2_15
LS3_1
LS3_5
LS4_11

KET

Life-science technologies & biotechnologies

Interessi di ricerca

Studio dei meccanismi di resistenza della cellula leucemica ed identificazione del ruolo patogenetico e prognostico di profili aberranti proteomici e metabolomici implicati nei meccanismi proliferativi ed apoptotici. Sviluppo preclinico di molecole sperimentali con potenziale ruolo terapeutico target-specifico nelle onco-emopatie. Studio dei profili proteomici e metabolomici in cellule staminali emopoietiche umane normali e nella controparte leucemica.

Keywords

Acute leukemia

molecular targeted therapies

drug resistance

cell signaling

cell metabolism

Pubblicazioni

ERC

KET

Interessi di ricerca

Keywords

Progetti di Ricerca